ABBV vs LLY
AbbVie Inc · Eli Lilly and Company
Relative return (rebased to 100)
Key stats
| Metric | ABBV | LLY |
|---|---|---|
| Price | $255.00 | $1,123.00 |
| Market Cap | $450.61B | $1.06T |
| P/E | 106.63 | 51.22 |
| P/B | — | 31.20 |
| P/S | 7.37 | 16.22 |
| ROE | — | 60.9% |
| Net Margin | 6.9% | 31.7% |
| Gross Margin | — | — |
| Revenue Growth | 8.6% | 44.7% |
| Dividend Yield | 2.61% | 0.55% |
| EPS | $2.39 | $21.93 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.